Simplifying Global Compliance
HIV Pill for Prevention Debated as FDA Ruling Nears
An advocacy group concerned about costs and possible health problems related to a drug being considered to help stop the spread of HIV infection to healthy people has asked U.S. regulators to delay or deny its approval.
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing